Use of ICIs for Advanced Melanoma in Taiwanese Patients

Though yielding slightly inconclusive results, a new study demonstrates that ICIs can still provide an alternative option for Taiwanese melanoma patients seeking a robust response profile with tolerable toxicity.

Docs seek balance between tech advances, patient empathy


Medicine is going through growing and shrinking pains at the same time. Conferences like MedX illuminate where we are falling short with our patients and where opportunities for change exist.